Učitavanje...

LGG-27. TARGETED THERAPY FOR PEDIATRIC LOW-GRADE GLIOMAS AND PLEXIFORM NEUROFIBROMAS WITH TRAMETINIB

BACKGROUND: Targeted therapy aimed at modulating the RAS/RAF/MEK/ERK pathway is of increasing interest for patients with plexiform neurofibromas and low-grade gliomas. Trametinib is an FDA-approved MEK inhibitor that has little published pediatric experience to date. METHODS: A retrospective chart r...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Nguyen, Tiffany, McMahon, Kathleen, Hemenway, Molly, Levy, Jean Mulcahy, Foreman, Nicholas, Dorris, Kathleen
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715454/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.409
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!